Cargando…
Design, Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy
Protein arginine methyltransferases 5 (PRMT5) is a clinically promising epigenetic target that is upregulated in a variety of tumors. Currently, there are several PRMT5 inhibitors under preclinical or clinical development, however the established clinical inhibitors show favorable toxicity. Thus, it...
Autores principales: | Tang, Yixuan, Huang, Shihui, Chen, Xingxing, Huang, Junzhang, Lin, Qianwen, Huang, Lei, Wang, Shuping, Zhu, Qihua, Xu, Yungen, Zou, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572541/ https://www.ncbi.nlm.nih.gov/pubmed/36235174 http://dx.doi.org/10.3390/molecules27196637 |
Ejemplares similares
-
Design, Synthesis, and Biological Evaluation of Potent and Selective Inhibitors of Ataxia Telangiectasia Mutated and Rad3-Related (ATR) Kinase for the Efficient Treatment of Cancer
por: Shao, Jialu, et al.
Publicado: (2023) -
Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5
por: Al-Hamashi, Ayad A., et al.
Publicado: (2021) -
Exploration of Cyanine Compounds
as Selective Inhibitors of Protein Arginine Methyltransferases: Synthesis
and Biological Evaluation
por: Hu, Hao, et al.
Publicado: (2015) -
Discovery of Potent
and Selective Allosteric Inhibitors
of Protein Arginine Methyltransferase 3 (PRMT3)
por: Kaniskan, H. Ümit, et al.
Publicado: (2017) -
Discovery of Potent and Selective Covalent Protein
Arginine Methyltransferase 5 (PRMT5) Inhibitors
por: Lin, Hong, et al.
Publicado: (2019)